These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15976351)

  • 1. Gastrointestinal stromal tumour treated with neoadjuvant imatinib.
    Loughrey MB; Mitchell C; Mann GB; Michael M; Waring PM
    J Clin Pathol; 2005 Jul; 58(7):779-81. PubMed ID: 15976351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical management after neoadjuvant imatinib therapy in gastrointestinal stromal tumours (GISTs) with respect to imatinib resistance caused by secondary KIT mutations.
    Haller F; Detken S; Schulten HJ; Happel N; Gunawan B; Kuhlgatz J; Füzesi L
    Ann Surg Oncol; 2007 Feb; 14(2):526-32. PubMed ID: 17139461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DW MRI for evaluation of treatment response to imatinib in a rectal gastrointestinal stromal tumour.
    Revheim ME; Hole KH; Bruland OS; Haugland HK; Hall KS; Seierstad T
    Acta Oncol; 2011 Jan; 50(1):148-50. PubMed ID: 21110775
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hepatic metastasis from gastric GIST radically resected after imatinib mesylate therapy-a case report].
    Kittaka H; Yamada T; Goto K; Ogawa H; Shingai T; Motoori M; Takahashi H; Kishi K; Noura S; Miyashiro I; Ohue M; Ohigashi H; Yano M; Ishikawa O
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2508-10. PubMed ID: 22202429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Successful resection of a gastrointestinal stromal tumor in the pelvis with imatinib mesylate as neoadjuvant therapy].
    Nakajima N; Kato S; Usui Y; Shinozaki T; Soeda S; Kawakami M; Kim H; Hanai K; Hoshi A; Nomoto T; Terachi T; Sadahiro S
    Hinyokika Kiyo; 2011 Mar; 57(3):135-9. PubMed ID: 21586885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neoadjuvant therapy with imatinib mesilate for gastrointestinal stromal tumor of the stomach before subsequent successful surgical resection].
    Yamamoto K; Imamura H; Furukawa H; Kishimoto T; Miyazaki Y; Ohshiro R; Tatsuta M; Ohsato H; Fukunaga M; Nakayama T; Fujimi S; Takemoto H; Kondo M; Kamigaki S; Ohta K; Nakata Y
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1875-7. PubMed ID: 17212133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of patients with gastrointestinal stromal tumour with imatinib mesylate].
    Haugland HK; Jebsen NL; Mannelqvist M; Skar R; Eide J; Øvrebø K; Horn A; Jensen DK; Monge OR; Lilleng PK
    Tidsskr Nor Laegeforen; 2005 Apr; 125(7):868-72. PubMed ID: 15815732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of Giant GIST of the stomach successfully treated with imatinib mesylate neoadjuvant therapy and followed postoperatively].
    Okuda H; Tanaka H; Ueno M; Shitani M; Nasuno M; Suzuki C; Nishimura S; Kimura H; Yonezawa K; Abe T; Yoshida Y; Kawabata M
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1941-4. PubMed ID: 16282731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent GI bleeding and surgery following the initial response to imatinib therapy in GIST of the stomach.
    El Hajj II; Chehal A; El Saghir NS
    Dig Dis Sci; 2005 Jan; 50(1):65-9. PubMed ID: 15712639
    [No Abstract]   [Full Text] [Related]  

  • 10. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib.
    Andtbacka RH; Ng CS; Scaife CL; Cormier JN; Hunt KK; Pisters PW; Pollock RE; Benjamin RS; Burgess MA; Chen LL; Trent J; Patel SR; Raymond K; Feig BW
    Ann Surg Oncol; 2007 Jan; 14(1):14-24. PubMed ID: 17072676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal stromal tumour in a young adult.
    Samuel DO; Philip I; Omotara SM
    J Coll Physicians Surg Pak; 2010 Sep; 20(9):618-9. PubMed ID: 20810057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological response of gastrointestinal stromal tumour to imatinib treatment correlates with tumour KIT mutational status in individual tumour clones.
    Loughrey MB; Beshay V; Dobrovic A; Zalcberg J; Waring PM
    Histopathology; 2006 Jul; 49(1):99-100. PubMed ID: 16842259
    [No Abstract]   [Full Text] [Related]  

  • 13. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
    Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
    Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of huge GIST of the stomach successfully resected following effective neoadjuvant chemotherapy.
    Tanaka N; Saka M
    Jpn J Clin Oncol; 2008 Nov; 38(11):790. PubMed ID: 18952707
    [No Abstract]   [Full Text] [Related]  

  • 15. Downstaging of a gastric GIST by neoadjuvant imatinib and endoscopic assisted laparoscopic resection.
    Cavaliere D; Vagliasindi A; Mura G; Framarini M; Giorgetti G; Solfrini G; Tauceri F; Padovani F; Milandri C; Dubini A; Ridolfi L; Ricci E; Verdecchia GM
    Eur J Surg Oncol; 2007 Oct; 33(8):1044-6. PubMed ID: 17467951
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of gastrointestinal stromal tumors in the imatinib era: selected case studies.
    Benjamin RS; Blanke CD; Blay JY; Bonvalot S; Eisenberg B
    Oncologist; 2006 Jan; 11(1):9-20. PubMed ID: 16401709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant treatment of rectal gastrointestinal stromal tumors with imatinib.
    Turner J; Batus M; Leslie W; Coogan C; Saclarides TJ
    Am Surg; 2010 Aug; 76(8):E110-2. PubMed ID: 21513625
    [No Abstract]   [Full Text] [Related]  

  • 18. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors.
    Seshadri RA; Rajendranath R
    J Cancer Res Ther; 2009; 5(4):267-71. PubMed ID: 20160360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors.
    Rutkowski P; Debiec-Rychter M; Nowecki ZI; Wozniak A; Michej W; Limon J; Siedlecki JA; Jerzak Vel Dobosz A; Grzesiakowska U; Nasierowska-Guttmejer A; Sygut J; Nyckowski P; Krawczyk M; Ruka W
    Med Sci Monit; 2007 Nov; 13(11):CR515-522. PubMed ID: 17968300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of neoadjuvant Imatinib therapy on outcome and survival after rectal gastrointestinal stromal tumour.
    Machlenkin S; Pinsk I; Tulchinsky H; Ziv Y; Sayfan J; Duek D; Rabau M; Walfisch S
    Colorectal Dis; 2011 Oct; 13(10):1110-5. PubMed ID: 21040362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.